our
companyboard of directors
TransMolecular's board of directors bring a wealth of business experience in operations, management, business development, and financing of early through public stage biotechnology companies. The board members are instrumental in assisting the Company's management team in advising and developing the overall strategic direction of the Company.
Nicholas C. Nicolaides, Ph.D., Chairman
President & CEO, Morphotek, Inc.
Lyle Hohnke, Ph.D.
Principal, Tullis-Dickerson & Co., Inc.
Hubert Birner, Ph.D.
General Partner, TVM Capital
Frank Garcia
Easton Capital Investment Group
Hans Mueller, Ph.D.
HM Consulting
Robert Radie
President & CEO, TransMolecular, Inc.